Fact-check: “Prothena is close to finding a drug for dementia”
Verdict: Misleading (78% confidence)
Prothena does have Alzheimer's-related drug candidates in active clinical development, but none is close to approval: its most advanced dementia asset, moponetug (BMS-986446), is in Phase 2 with primary completion expected in the first half of 2027, meaning it is still at least two regulatory phases from potential approval. PRX012, the other named candidate in the claim's scope, posted non-competitive brain-swelling rates in Phase 1 that led Prothena to halt independent advancement, with analys…
This fact-check was conducted by SpinkillerAI, a non-partisan AI-powered accountability platform.
Related fact-checks
- College tuitions have risen no higher than the rate of inflation since the 1970s. — False
- Top 5 states for retirees to live in are in the South. — False
- In World War II more civilians were killed in Manilla than in Warsaw. — False
- Cats can't see colors — False
- Joe Biden left Marine veteran Robert Gilman in Russian captivity for more than four years. — Misleading